In contrast, the bivalent [64Cu]Cu-α-EGFR-EGFR-NODAGA TM has not reached its maximum concentration 1.5 h p.i. and can further enrich at the tumor site during the following 22.5 h (Figure 14B, red bars, see also Figure 12). Here, EGFR is linked to neoplasm.